Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
50 , e330e335 (2021)
[PMID: 9102927] PubMed record related to this compound for laboratory literature review
This is the foundation of scientific integrity and allows researchers to generate reliable and reproducible data for publication
She told Vogue that she gets her protein fill from beans
Head-to-head trials should compare long-term benefits of different combination regimens
This study is a global, randomized, double-blind, placebo-controlled clinical trial (n=11000) aimed at evaluating the effectiveness and safety of Zilebesiran (300mg, subcutaneous injection, once every 6 months) combined with standard treatment (OC) compared to placebo combined with SOC in reducing the incidence of major cardiovascular adverse events (MACE) in hypertensive adult patients with diagnosed cardiovascular disease or poor blood pressure control at high risk of cardiovascular disease
US$ 24.19
US$ 27.10
US$ 26.55
US$ 26.85
US$ 20.55
US$ 20.08
